Endoven Pharmaceuticals Private Limited

Produces a wide range of pharmaceutical products, including tablets, capsules, and liquid medications.

1998 | Hyderabad, Telangana (India) | Active
Last Updated:

Endoven Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.72 Cr
  • Company Age 26 Year, 11 Months
  • Last Filing with ROC 31 Mar 2010
  • Open Charges ₹ 15.50 Cr
  • Satisfied Charges ₹ 0.71 M

About Endoven Pharmaceuticals

Endoven Pharmaceuticals Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 June 1998 and has a history of 26 years and 11 months. Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.72 Cr.

The company currently has active open charges totaling ₹15.50 Cr. The company has closed loans amounting to ₹0.71 M, as per Ministry of Corporate Affairs (MCA) records.

Yerramilli Raju and Suvarchala Yerramilli serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230TG1998PTC029624

  • Company No.

    029624

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    19 Jun 1998

  • Date of AGM

    30 Sep 2010

  • Date of Balance Sheet

    31 Mar 2010

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma
Company report

Endoven Pharmaceuticals Private Limited

Explore comprehensive data for Endoven Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Endoven Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Yerramilli Raju Country flag representing In Director 01-Apr-2009Current
Suvarchala Yerramilli Country flag representing In Director 01-Apr-2009Current

Financial Performance of Endoven Pharmaceuticals.

Enhance accessibility to Endoven Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Endoven Pharmaceuticals revenue growth over time
Endoven Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Endoven Pharmaceuticals?

Unlock access to Endoven Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹15.50 Cr

Satisfied Charges

₹0.07 Cr

Charges Breakdown by Lending Institutions

  • Union Bank Of India : 15.50 Cr

Latest Charge Details

DateLenderAmountStatus
25 Mar 2009Union Bank Of India₹5.50 CrOpen
01 Oct 2008Union Bank Of India₹10.00 CrOpen
25 Apr 2005The Lakshmi Vilas Bank Ltd₹0.71 MSatisfied

How Many Employees Work at Endoven Pharmaceuticals?

Unlock and access historical data on people associated with Endoven Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Endoven Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Endoven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endoven Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Endoven Pharmaceuticals

Recent activity within the organization

  • Charges

    A charge registered on 25 Apr 2005 via Charge ID 90121890 with The Lakshmi Vilas Bank Ltd was fully satisfied on 19 Jan 2012.

  • Annual General Meeting

    Endoven Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records.

  • Balance Sheet

    Endoven Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Hyderabad.

  • Director Appointment

    Yerramilli Venkata Surya Sanyasi Raju was appointed as a Director was appointed as a Director on 01 Apr 2009 & has been associated with this company since 16 years 1 month .

  • Director Appointment

    Suvarchala Yerramilli was appointed as a Director was appointed as a Director on 01 Apr 2009 & has been associated with this company since 16 years 1 month .

  • Charges

    A charge with Union Bank Of India amounted to Rs. 5.50 Cr with Charge ID 10158327 was registered on 25 Mar 2009.

Frequently asked questions

  • What is the Incorporation or founding date of Endoven Pharmaceuticals Private Limited?

    Endoven Pharmaceuticals Private Limited was incorporated on 19 Jun 1998.

  • What is authorized share capital and paid-up capital of Endoven Pharmaceuticals Private Limited?

    The authorized share capital of Endoven Pharmaceuticals Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 3.72 Cr.

  • Who are the current board members & directors of Endoven Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Endoven Pharmaceuticals Private Limited.

    • Yerramilli Venkata Surya Sanyasi Raju
    • Suvarchala Yerramilli

  • What is the registered address of Endoven Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Endoven Pharmaceuticals Private Limited is 17/3Rt, Opp:Andhra Bank Lanes R Nagar Hyderabad. India, A.P., Telangana, 500038.

  • What is the corporate identification number (CIN) and company number of Endoven Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Endoven Pharmaceuticals Private Limited is U24230TG1998PTC029624 and the company number is 029624 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Endoven Pharmaceuticals Private Limited?

    The Official website of Endoven Pharmaceuticals Private Limited is https://www.vanguardgroup.in

  • What are the total open charges for Endoven Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 0, The total open charges for Endoven Pharmaceuticals Private Limited amount to ₹ 15.50 Cr.

  • When was the last Balance Sheet of Endoven Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Endoven Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2010.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development